Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
338 hedge funds and large institutions have $1.98B invested in Avanos Medical in 2018 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 80 increasing their positions, 120 reducing their positions, and 38 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less capital invested
Capital invested by funds: $1.99B → $1.98B (-$8.41M)
3% less funds holding
Funds holding: 350 → 338 (-12)
21% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 38
22% less call options, than puts
Call options by funds: $2.58M | Put options by funds: $3.33M
33% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 120
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$35.7M |
| 2 |
CCM
Channing Capital Management
Chicago,
Illinois
|
+$30.1M |
| 3 |
HM
HealthCor Management
New York
|
+$29.8M |
| 4 |
Select Equity Group
New York
|
+$22.7M |
| 5 |
Renaissance Technologies
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$30.6M |
| 2 |
CSC
Cove Street Capital
El Segundo,
California
|
-$16.6M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.5M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$16.4M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$12.7M |
AVNS Hedge Fund Activity: Q1 2018 in Review
338 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2018, worth a combined $1.98B — down 0.42% from $1.99B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of AVNS and 30 opened new positions — a net loss of 8 holders — while 120 trimmed existing stakes and 80 added.
The largest buyer was Champlain Investment Partners, opening a new position worth an estimated $35.7M. The largest seller was JP Morgan Chase, cutting an estimated $30.6M.
- 338 institutional investors held Avanos Medical (AVNS) as of Q1 2018, down from 350 in Q4 2017.
- Funds reported $1.98B of Avanos Medical stock for Q1 2018, down 0.42% quarter-over-quarter.
- 30 funds opened new Avanos Medical positions in Q1 2018 and 38 closed out, a net change of -8 holders.
- The largest Avanos Medical buyer in Q1 2018 was Champlain Investment Partners, an estimated $35.7M added.
- The largest Avanos Medical seller in Q1 2018 was JP Morgan Chase, an estimated $30.6M sold.
Based on aggregated 13F filings for Q1 2018.